1-(4´-METOKSIFENIL)-6,7DIMETOKSI-1,2,3,4-TETRAGIDROIZOXINOLINNING TUTQANOQQA QARSHI FAOLLIGI
Article Sidebar
Это произведение доступно по лицензии Creative Commons «Attribution» («Атрибуция») 4.0 Всемирная.
Main Article Content
Аннотация:
Ushbu maqolada sintetik birikma 1-(4´-metoksifenil)-6,7-dimetoksi-1,2,3,4-tetragidroizoxinolin kam zaharli sinfga mansub ekanligi, 0.1; 0.5; 1.0; 5.0 va 10.0 mg/kg dozalarda psixofarmakologik faolliklari va tutqanoqqa qarshi solishtirma preparatlar karbamazepin va konvuleksdan qolishmasligi eksperimental tajribalar asosida tasdiqlangan.
Article Details
Как цитировать:
Библиографические ссылки:
R. S. Fisher, W. van Emde Boas, W. Blume, C. Elger, P. Genton, P. Lee and J. J. Engel, “Epileptic Seizures and Epilepsy: Definitions Proposed by the International League against Epilepsy (ILAE) and the International Bureau for Epilepsy (IBE),” Epilepsia, Vol. 46, No. 4, 2005, pp. 470- 472. doi:10.1111/j.0013-9580.2005.66104.x
C. Gerlach and J. L. Krajewski, “Antiepileptic Drug Discovery and Development: What Have We Learned and Where Are We Going?” Pharmaceuticals, Vol. 3, No. 9, 2010, pp. 2884-2899. doi:10.3390/ph3092884
Chimirri, G. De Sarro, A. De Sarro, R. Gitto, S. Grasso, S. Quartarone, M. Zappalà, P. Giusti, V. Libri, A. Constanti and A. G. Chapman, “1-Aryl-3,5-dihydro- 4H-2,3-benzodiazepin-4-ones: Novel AMPA Receptor Antagonists,” Journal of Medicinal Chemistry, Vol. 40, No. 8, 1997, pp. 1258-1269. doi:10.1021/jm960506l
Chimirri, G. De Sarro, A. De Sarro, R. Gitto, S. Quartarone, M. Zappalà, A. Constanti and V. Libri, “3,5- Dihydro-4H-2,3-benzodiazepine-4-thiones: A New Class of AMPA Receptor Antagonists,” Journal of Medicinal Chemistry, Vol. 41, No. 18, 1998, pp. 3409-3416. doi:10.1021/jm9800393
M. Zappalà, R. Gitto, F. Bevacqua, S. Quartarone, A. Chimirri, M. Rizzo, G. D. Sarro and A. D. Sarro, “Synthesis and Evaluation of Pharmacological and Pharmacokinetic Properties of 11H-[1,2,4]triazolo[4,5-c][2,3] benzodiazepin-3(2H)-ones,” Journal of Medicinal Chemistry, Vol. 43, No. 25, 2000, pp. 4834-4839. doi:10.1021/jm001012y
M. Zappalà, G. Postorino, N. Micale, S. Caccamese, N. Parrinello, G. Grazioso, G. Roda, F. S. Menniti, G. D. Sarro and S. Grasso, “Synthesis, Chiral Resolution, and Enantiopharmacology of a Potent 2,3-benzodiazepine Derivative as Noncompetitive AMPA Receptor Antagonis,” Journal of Medicinal Chemistry, Vol. 49, No. 2, 2006, pp. 575-581. doi:10.1021/jm050552y
Y. Wang, C. S. Konkoy, V. I. Ilyin, K. E. Vanover, R. B. Carter, E. Weber, J. F. Keana, R. M. Woodward and S. X. Cai, “Synthesis of 7,8-(Methylenedioxy)-1-phenyl-3,5-dihydro-4H-2,3-benzodiazepin-4-ones as Novel and Potent Noncompetitive AMPA Receptor Antagonists,” Journal of Medicinal Chemistry, Vol. 41, No. 14, 1998, pp. 2621- 2625. doi:10.1021/jm980168j
G. Abrahám, S. Sólyom, E. Csuzdi, P. Berzsenyi , I. Ling, I. Tarnawa, T. Hámori, I. Pallagi, K. Horváth, F. Andrási,
G. Kapus, L. G. J. Hársing, I. Király, M. Patthy and G. Horváth, “New Noncompetitive AMPA Antagonists,” Bioorganic & Medicinal Chemistry, Vol. 8, No. 8, 2000, pp. 2127-2143 doi:10.1016/S0968-0896(00)00133-4
T. Hámore, S. Sólyom, P. Berzsenyi, F. Andrási and I. Tarnawa, “Structural Analogues of Some Highly Active Non-Competitive AMPA Antagonists,” Bioorganic & Medicinal Chemistry Letters, Vol. 10, No. 9, 2000, pp. 899- 902. doi:10.1016/S0960-894X(00)00117-7
S. Grasso, G. De Sarro, A. De Sarro, N. Micale, M. Zappalà, G. Puia, M. Baraldi and C. D. Micheli, “Synthesis and Anticonvulsant Activity of Novel and Potent 2,3- benzodiazepine AMPA/Kainate Receptor Antagonists,” Journal of Medicinal Chemistry, Vol. 42, 1999, pp. 4414- 4421. doi:10.1021/jm991086d
J. J. Luszczki, “Third-Generation Antiepileptic Drugs: Mechanisms of Action, Pharmacokinetics and Interactions,” Pharmacological Reports, Vol. 61, No. 2, 2009, pp. 197-216
M. L. Barreca, R. Gitto, S. Quartarone, D. L. Luca, G. D. Sarro and A. Chimirri, “Pharmacophore Modeling as an Efficient Tool in the Discovery of Novel Noncompetitive,” Journal of Chemical Information and Modeling, Vol. 43, No. 2, 2003, pp. 651-655. doi:10.1021/ci025625q
J. F. Howes and C. Bell, “Talampanel,” Neurotherapeutics, Vol. 4, No. 1, 2007, pp. 126-129.doi:10.1016/j.nurt.2006.11.001
R. Gitto, R. Caruso, V. Orlando, S. Quartarone, M. L. Barreca, G. Ferreri, E. Russo, G. D. Sarro and A. Chimirri, “Synthesis and Anticonvulsant Properties of Tetrahydroisoquinoline Derivative,” Farmaco, Vol. 59, No. 1, 2004, pp. 7-12. doi:10.1016/j.farmac.2003.10.003
Magdalena Białońet al. 1MeTIQ and olanzapine, despite their neurochemical impact, did not ameliorate performance in fear conditioning and social interaction tests in an MK-801 rat model of schizophrenia. Pharmacol Rep. 2021 Jan 6.doi: 10.1007/s43440-020-00209-9.
Agnieszka Wąsik, Irena Romańska, Agnieszka Zelek-Molik, Lucyna Antkiewicz-Michaluk. Multiple Administration of Endogenous Amines TIQ and 1MeTIQ Protects Against a 6-OHDA-Induced Essential Fall of Dopamine Release in the Rat Striatum: In Vivo Microdialysis Study. Neurotox Res. 2018 Apr;33(3):523-531.doi: 10.1007/s12640-017-9824-8.Epub 2017 Oct 26.
Lucyna Antkiewicz-Michaluket al. The mechanism of 1,2,3,4-tetrahydroisoquinolines neuroprotection: the importance of free radicals scavenging properties and inhibition of glutamate-induced excitotoxicity. J Neurochem. doi: 10.1111/j.1471-4159.2006.03756.x.Epub 2006 Mar 3.
E. Możdżeń et al. 1,2,3,4-Tetrahydroisoquinoline produces an antidepressant-like effect in the forced swim test and chronic mild stress model of depression in the rat: Neurochemical correlates/ European Journal of Pharmacology 729 (2014) 107–115
E. Możdżeń et al. Antidepressant-like effect of 1,2,3,4-tetrahydroisoquinoline and its methyl derivative in animal models of depression. Pharmacological Reports. PubDate2017-02-08, DOI:10.1016/j.pharep.2017.01.032
Jurakulov Sh.N., Vinogradova V.I., Levkovich M.G. /Sintez 1-ariltetragidro-izoxinolinovix alkaloidov i ix analogov. //Ximiya prirod. soedin., 2013, s. 62-66.
Sanoev Z.I., Mirzaev Yu.R. Pharmacological Activity Of The Possessing New Atypical Neuroleptics 1-Phenyltetrahydroisoquinoline Structure. The American Journal of Medical Sciences and Pharmaceutical Research Published: 2020|Pages:18-26 https://doi.org/10.37547/TAJMSPR/Volume02Issue08-03
Sanoev Z.I., Mirzaev Y.R. Research of a new atypical neuroleptic 1-(3,4,-methylenedioxyphenyl)-6,7-methylenedioxy-1,2,3,4-tetrahydroisoquinoline on the central nervous system. Annals of the Romanian Society for Cell Biology, 2021, 25 (2), 2363–2369
Мирзаев Ю. Р., Саноев З. И., Жўрақулов Ш. Н., & Виноградова В. И. (2015). Психофармакологические свойства производного тетрагидроизохинолина. Международный научный журнал “Unity of Science” Вена, Австрия, 170-174.
Yakubova L.K. Sanoev Z.I., Mirzaev Yu.R. Comparative pharmacological properties of a derivative of tetrahydroisoquinoline and seduxen. New Dey in Medicine. 2 (30/2) 2020, p. 365-368
European Convention for the Protection of Vertebrate Animals Used for Experimental and Other Scientific Purposes, ETS No123, Strasbourg (1986).
Mironov A.N. Rukovodstvo po provedeniyu doklinicheskix issledovaniy lekarstvennix sredstv. Chast pervaya. –M.: Grifi K, 2012. -944 s.
Li, M. Anticonvulsant activity of B2, an adenosine analog, on chemical convulsant-induced seizures / M. Li, R. Kang, J. Shi [et al.] // PLoS One. –2013. –T. 8. –No. 6. –S. e67060.
Khatoon, H. Evaluation of anticonvulsant and neuroprotective effects of camel milk in strychnine-induced seizure model / H. Khatoon, R. Najam, T. Mirza [et al.] // Asian Pacific Journal of Tropical Disease. –2015. –T. 5. –No. 10. –S. 817-820.